Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha lipoic acid for salivary protection during head and neck radiotherapy
IRCT20221219056864N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alpha-lipoic acid in head and neck cancer (HNC), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Change in saliva amount. Started Jul 2023; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on IRCT20221219056864N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221219056864N1.